Nick Hern Books.
Our price: £9.50 + £1.20 p&p (rrp £12.99)
Pre-order now – we’ll have them in stock 15 January.

A truthful, personal and insightful exploration of the state of arts funding and carrying on in the face of adversity, by the renowned founder of Out of Joint.

One March morning, out of the blue, Max Stafford-Clark learned that the Arts Council had drastically cut their grant to his theatre company, Out of Joint, leaving it in danger of imminent collapse. Journal of the Plague Year is his account of what happened next, as he sets out to contest the cut, make the case for public funding of the arts, and continue producing the work for which he and his company are renowned.
Max’s journal often takes on an autobiographical flavour, including the unexpectedly moving story of his two fathers, his surreal encounter with the New York theatre world, and the shocking details of what it is to suffer a massively debilitating stroke.

By turns funny, alarming and deeply personal, Journal of the Plague Year offers a fascinating exposé of the often Kafkaesque workings of arts subsidy in England, and the financial and artistic maneuverings which are a fact of life for every arts organisation today. It is essential reading for anyone with an interest in the state of our arts, from students to theatregoers, and from struggling arts workers right up to the Secretary of State for Culture.









Subscribe to our mailing list

* indicates required
As well as shows & news I am interested in:

Out of Joint will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at jon@outofjoint.co.uk. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.